Credits Available: 4.75 AMA PRA Category 1 Credits

Description: Immune-mediated inflammatory diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, can prove challenging to address in real-world settings. Although biologics directed against TNF-α can rapidly and sustainably induce clinical remission of these conditions, they have incomplete efficacy; many other conventional treatments used alongside biologics additionally have complex safety profiles that limit their use. These limitations have spurred the development and examination of novel agents, such as Janus Kinase (JAK) inhibitors, in patients with inadequately controlled disease. Through this three-part, small-group educational program, rheumatologists and other supporting healthcare providers can gain greater familiarity with the mechanisms of action behind different JAK inhibitors, evaluate their efficacy and safety in different patient populations, and become acquainted with strategies to improve access to these agents on behalf of their patients. In doing so, clinicians can ensure that the next generation of therapies for immune-mediated inflammatory diseases are used to their fullest potential.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Assistant, Pharmacist, MBBS, MBBCh
Target Specialties: Rheumatology, Dermatology

Maureen Knell

University of Missouri Kansas City School of Pharmacy
Clinical Professor

Dr. Maureen Knell, PharmD, BCACP, is a Clinical Professor in the Division of Pharmacy Practice and Administration at the University of Missouri-Kansas City (UMKC) School of Pharmacy. She earned her Doctor of Pharmacy degree from UMKC and completed a Pharmacy Practice Residency at the University of Nebraska Medical Center. After several years in health-system pharmacy, she transitioned to a full-time academic appointment and clinical practice in 1997.
Dr. Knell’s clinical practice is based in ambulatory care at the Saint Luke’s Internal Medicine Medical Education Clinic in Kansas City, Missouri, where she is actively involved in interprofessional, patient-centered care. She collaborates with physicians, nurses, medical students, and other healthcare professionals to manage chronic disease states, with a particular focus on chronic pain, diabetes mellitus, heart failure, dyslipidemia, and other cardiovascular and internal medicine conditions. She and a physician colleague also co-manage a group of predominantly underserved chronic pain patients.
In addition to her clinical responsibilities, Dr. Knell precepts pharmacy students and residents in experiential rotations and teaches in the UMKC pharmacy, dental, and dental hygiene programs. Her scholarly interests include chronic pain management, arthritis, dietary supplement use, interprofessional education, personal and professional identity and healthcare delivery in underserved ambulatory care settings. She has presented at regional and national conferences and has authored multiple publications, including book chapters and peer-reviewed articles.
Dr. Knell has been recognized with several professional honors, including Missouri Health-System Pharmacist of the Year, two-time UMKC Preceptor of the Year, and UMKC Teacher of the Year.